Drug Profile
Solifenacin/tamsulosin - Jeil Pharmaceutical
Alternative Names: JLP-1207Latest Information Update: 29 Sep 2021
Price :
$50
*
At a glance
- Originator Jeil Pharmaceutical
- Class Amines; Antispasmodics; Benzene derivatives; Esters; Ethers; Isoquinolines; Quinuclidines; Small molecules; Sulfonamides; Urologics
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Cholinergic receptor antagonists; Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Benign prostatic hyperplasia
- Discontinued Overactive bladder
Most Recent Events
- 29 Sep 2021 Phase III development in Benign prostate hyperplasia (In adults, In the elderly) is ongoing in South Korea (PO) (Jeil Pharmaceutical website, September 2021)
- 29 Sep 2021 Discontinued - Phase-I for Overactive bladder (In volunteers) in South Korea (PO)
- 28 Jan 2019 Chemical structure information added